Brainsway - About the company
Brainsway is a public company based in Jerusalem (Israel), founded in 2003. It operates as a Develoepr of noninvasive neurostimulation treatments for mental health disorders. Brainsway has raised an undisclosed amount in funding. The company has 17 active competitors, including 6 funded and 3 that have exited. Its top competitors include companies like Flow Neuroscience, NeuroStar and Neuronetics.
Company Details
Develoepr of noninvasive neurostimulation treatments for mental health disorders. The company uses proprietary technology is Deep TMS, or Deep Transcranial Magnetic Stimulation, which launches a new era in brain disorder treatment. It is used to treat depressive episodes in patients suffering from Major Depressive Disorder.
- Website
- brainsway.com
- Email ID
- *****@brainsway.com
Key Metrics
Founded Year
2003
Location
Jerusalem, Israel
Stage
Public
Latest Funding Round
Investors
Ranked
6th among 17 active competitors
Annual Revenue
£0 - £1M as on Mar 31, 2023
Employee Count
145 as on Aug 31, 2026
Similar Companies
Exit Details
Public
Legal entities associated with Brainsway
Brainsway is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Brainsway Ltd CIN: 0513890764 , Israel, Active | Jul 11, 2006 | $10M - $50M (As on Dec 31, 2023) | - | - |
SWAY SOLUTIONS LIMITED CIN: 9414138 , United Kingdom, Active | Jan 29, 2015 | £0 - £1M (As on Mar 31, 2023) | 1 (As on Mar 31, 2025) |
Brainsway's IPO details
Brainsway got listed on Feb 25, 2010.
Click here to take a look at Brainsway's IPO in detail
Sign up to download Brainsway's company profile
Brainsway's funding and investors
Brainsway has raised funding over 4 rounds. Its first funding round was on Mar 11, 2014. Its latest funding round was a Post IPO round on Sep 29, 2024 for $*****. 1 investor participated in its latest round. Brainsway has 6 institutional investors.
Here is the list of recent funding rounds of Brainsway:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 29, 2024 | 9388410 | Post IPO | 2487553 | 3622345 | 7519288 | 2550949 |
Dec 11, 2017 | 2643838 | Post IPO | 8833615 | 1296121 | 9942982 | |
Jan 01, 2016 | 6934580 | Grant (prize money) | 8290030 | 7539709 | 9815398 |
View details of Brainsway's funding rounds and investors
Brainsway's founders and board of directors
Founder? Claim ProfileBrainsway's employee count trend
Brainsway has 145 employees as of Aug 26. Here is Brainsway's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Brainsway's Competitors and alternates
Top competitors of Brainsway include Flow Neuroscience, NeuroStar and Neuronetics. Here is the list of Top 10 competitors of Brainsway, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Flow Neuroscience 2016, Malmo (Sweden), Series A | Provider of a wearable device for stress and anxiety management | $11.9M | 61/100 | |
2nd | NeuroStar 2003, Malvern (United States), Public | Provider of a non-drug non-invasive therapeutic devices for neurorehabilitation | $119M | 60/100 | |
3rd | Neuronetics 2001, Malvern (United States), Series G | Transforming neurohealth with innovative, non-drug TMS therapy for mental health | $178M | 60/100 | |
4th | Magnus Medical 2017, Burlingame (United States), Series B | Provider of non invasive neuromodulation system for depression treatment | $65.3M | 54/100 | |
5th | Magstim 1990, Whitland (United Kingdom), Acquired | Developer of EEG, TMS, and tDCS neurotechnology solutions | $32.1M | 51/100 | |
6th | Develoepr of noninvasive neurostimulation treatments for mental health disorders | - | 46/100 | ||
7th | Soterix Medical 2008, New York City (United States), Funding Raised | Neuromodulation and brain stimulation technology for neuropsychiatric and neurological disorders | - | 41/100 | |
8th | ![]() Magnus 2020, Burlingame (United States), Series C | Provider of transcranial magnetic stimulation therapy for major depressive disorder | $49M | 39/100 | |
9th | Manufacturer of transcranial magnetic stimulation (TMS) systems for research and treatment | - | - | 39/100 | |
10th | Neuroprex 2012, Santa Clara (United States), Seed | Developer of a wearable device to modulate tissue for neurological diseases | $50K | 32/100 |
Looking for more details on Brainsway's competitors? Click here to see the top ones
Brainsway's Investments and acquisitions
Brainsway has not made any acquisitions yet. Brainsway has made 5 investments.Here is the list of latest three $investments:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Mar 30, 2026 | Investments | 2012 | Herzliya (Israel) | |
Feb 19, 2026 | Investments | Vancouver (Canada) | ||
Aug 21, 2025 | Investments | 2012 | Herzliya (Israel) |
See all investments by Brainsway
Reports related to Brainsway
Here is the latest report on Brainsway's sector:
News related to Brainsway
Media has covered Brainsway for a total of 20 events in the last 1 year, 4 of them have been about company updates.
•
•
•
BrainsWay Invests $500,000 in Sound Minds Behavioral for Minority StakeGlobeNewswire•Jul 16, 2026•Brainsway
•
•
BrainsWay Announces Increased Favorable Coverage for Accelerated Deep TMS ProtocolGlobeNewswire•Jun 22, 2026•Brainsway
•
BrainsWay Invests $1.5 Million in Hopemark Health for Minority StakeGlobeNewswire•May 18, 2026•Brainsway
•
BrainsWay Reports First Quarter 2026 Financial Results and Operational HighlightsGlobeNewswire•May 13, 2026•Brainsway
•
Neurolief Raises $6M to Fuel U.S. Rollout of At-Home Depression TherapyRefresh Miami•Mar 30, 2026•Brainsway, Neurolief
•
BrainsWay Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire•Mar 11, 2026•Brainsway
•
BrainsWay Announces New Minority-Stake Investment in BrainStim Health Inc.GlobeNewswire•Feb 19, 2026•Brainsway
Are you a Founder ?
FAQs about Brainsway
Explore our recently published companies
- Himsons - Vadodara based, 1988 founded, Unfunded company
- Com2uS Platform Corp - Unfunded company
- Just Print - Unfunded company
